github link
Accession IconGSE6891

Acute myeloid leukemia samples of samples =< 60yrs on HG-U133 plus 2

Organism Icon Homo sapiens
Sample Icon 537 Downloadable Samples
Technology Badge Icon Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)

Submitter Supplied Information

Description
The pretreatment karyotype of leukemic blasts is currently the key determinant in therapy decision-making in acute myeloid leukemia (AML). However, approximately fifty percent of AML patients, often carrying a normal karyotype, are currently unclassifiable based these established methods. Gene expression profiling has proven to be valuable for risk stratification of AML.
PubMed ID
Total Samples
537
Submitter’s Institution

Samples

Show of 0 Total Samples
Filter
Add/Remove
Accession Code
Title
Sex
Age
Specimen part
Disease
Disease stage
Processing Information
Additional Metadata
No rows found
Loading...